Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151423 (US8987314, B234) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151421 (US8987314, B232) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50525871 (CHEMBL4460999) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of hepatic lipase (unknown origin) | Bioorg Med Chem Lett 29: (2019) Article DOI: 10.1016/j.bmcl.2019.126673 BindingDB Entry DOI: 10.7270/Q2DN48G0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151465 (US8987314, B276) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151397 (US8987314, B208) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 0.800 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151266 (US8987314, B62) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151494 (US8987314, B305) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151441 (US8987314, B252) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.40 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151496 (US8987314, B307) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151268 (US8987314, B64) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151399 (US8987314, B210) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 1.90 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50506499 (CHEMBL4463265) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151554 (US8987314, B365) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.10 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151292 (US8987314, B88) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.20 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151432 (US8987314, B243) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.40 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151267 (US8987314, B63) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151473 (US8987314, B284) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151291 (US8987314, B87) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151409 (US8987314, B220) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151468 (US8987314, B279) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151396 (US8987314, B207) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.80 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151469 (US8987314, B280) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 2.90 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM24567 ((2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-...) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151462 (US8987314, B273) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM187287 (US9169240, 27) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151402 (US8987314, B213) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151404 (US8987314, B215) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151406 (US8987314, B217) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151422 (US8987314, B233) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 3.60 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50506506 (CHEMBL4465833) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50506505 (CHEMBL4460376) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM187290 (US9169240, 30) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151463 (US8987314, B274) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151407 (US8987314, B218) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 5.20 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50525869 (CHEMBL4587475) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 5.40 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of hepatic lipase (unknown origin) | Bioorg Med Chem Lett 29: (2019) Article DOI: 10.1016/j.bmcl.2019.126673 BindingDB Entry DOI: 10.7270/Q2DN48G0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151567 (US8987314, B378) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50522804 (CHEMBL4437751) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of human hepatic lipase expressed in African green monkey COS7 cells using PED-A1 as substrate incubated for 20 mins and measured every 20... | Bioorg Med Chem Lett 29: 1918-1921 (2019) Article DOI: 10.1016/j.bmcl.2019.05.048 BindingDB Entry DOI: 10.7270/Q2JH3QMN | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151297 (US8987314, B93) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151428 (US8987314, B239) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.30 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151412 (US8987314, B223) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 7.70 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50506500 (CHEMBL4471611) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 9 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151442 (US8987314, B253) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 9.40 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50521232 (CHEMBL4567596) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM151320 (US8987314, B118) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 10 | n/a | n/a | n/a | n/a | 8.0 | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artifi... | US Patent US8987314 (2015) BindingDB Entry DOI: 10.7270/Q2W094N8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50521233 (CHEMBL4458141) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50521230 (CHEMBL4546575) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50521225 (CHEMBL4440746) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50521236 (CHEMBL4589925) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | <10 | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Curated by ChEMBL | Assay Description Inhibition of recombinant human HL expressed in COS7 cells using PED-A1 containing DMPG vesicles as substrate pretreated for 20 mins followed by subs... | ACS Med Chem Lett 9: 1263-1268 (2018) Article DOI: 10.1021/acsmedchemlett.8b00424 BindingDB Entry DOI: 10.7270/Q2TF01QC | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM187289 (US9169240, 29) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Hepatic triacylglycerol lipase (Homo sapiens (Human)) | BDBM50506497 (CHEMBL4446812) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA Curated by ChEMBL | Assay Description Inhibition of human HL expressed in human COS7 cells using A10070 as substrate preincubated for 20 min followed by DMPG vesicle doped substrate addit... | J Med Chem 63: 1660-1670 (2020) Article DOI: 10.1021/acs.jmedchem.9b01831 BindingDB Entry DOI: 10.7270/Q28G8PZS | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 418 total ) | Next | Last >> |